Literature DB >> 36260626

In vitro cytotoxicity of human urine and its potential toxic parameters towards bladder cancer cells.

Hongda Zhao1, Ryan Tsz-Hei Tse1, Carol Ka-Lo Cheng1, Christine Yim-Ping Wong1, Angel Wing-Yan Kong1, Ronald Cheong-Kin Chan2, Peter Ka-Fung Chiu1, Chi-Fai Ng1, Jeremy Yuen-Chun Teoh1,3.   

Abstract

BACKGROUND: Bladder cancer (CaB) has a high recurrence rate despite surgery. As bladder is constantly filled with urine, it is worthwhile to investigate whether it could have any detrimental effects on bladder cancer cells.
METHODS: We investigated the cytotoxicity of urine samples from CaB patients and normal controls on four CaB cell lines and tested the percentage of cell death, proliferation, adhesion, invasion and colonies formation ability. In order to identify the potential components involving in urine cytotoxicity, we evaluated some basic physiochemical parameters of urines, such as pH, osmolarity, creatinine (Cr), sodium (Na), potassium (K), chloride (Cl), calcium (Ca) and phosphate (PO4). We further compared the pH values of urine samples between CaB who developed recurrence versus those who did not. A more in-depth analysis on inflammatory markers was performed for two representative urine samples which demonstrated opposite cytoxic effects.
RESULTS: 23 CaB patients and 20 normal controls were recruited into this study. According to in vitro experiments, both CaB and non-CaB urines had comparable effect on cell toxicity, proliferation, adhesion, invasion and colonies formation ability in four cell lines, HTB9, RT4, T24 and UMUC3, while RT4 was the most sensitive to urine toxicity. After evaluating the relationship between basic physiochemical parameters and cytotoxicity, we found out that there were strong negative correlations between pH value and 24 hours death rate for the 4 CaB cell lines (HTB9 r = -0.6651, p<0.001; RT4 r = -0.8335, p<0.001; T24 r = -0.4924, p<0.001; UMUC3 r = -0.7066, p<0.001). Osmolarity, urine Cr and PO4 all had weakly or moderately positive correlations with CaB cells on 24 hours death rate. CaB patients who developed recurrence had more alkaline urine than those who did not develop recurrence. In the urine sample with the highest cytoxicity, high concentrations of IL-6 and IFN-gamma were found.
CONCLUSIONS: Our study confirmed that there was not statistically significant difference in cytotoxicity between CaB and non-CaB urines. However, we identified some parameters that could have an impact on cytotoxicity towards CaB cells. Modifying certain urine characteristics peri-operatively may induce cytotoxicity, avoid tumour re-implantation, and reduce the chance of cancer recurrence.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36260626      PMCID: PMC9581372          DOI: 10.1371/journal.pone.0276127

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  20 in total

1.  Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.

Authors:  Hua Naranmandura; Michael W Carew; Shi Xu; Jane Lee; Elaine M Leslie; Michael Weinfeld; X Chris Le
Journal:  Chem Res Toxicol       Date:  2011-08-16       Impact factor: 3.739

Review 2.  Regulation of osmolality for cancer treatment.

Authors:  Atsushi Shiozaki; Daisuke Ichikawa; Toshiyuki Kosuga; Yoshinori Marunaka; Eigo Otsuji
Journal:  J Physiol Sci       Date:  2017-02-10       Impact factor: 2.781

Review 3.  Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?

Authors:  Richard J Sylvester; Willem Oosterlinck; Sten Holmang; Matthew R Sydes; Alison Birtle; Sigurdur Gudjonsson; Cosimo De Nunzio; Kikuo Okamura; Eero Kaasinen; Eduardo Solsona; Bedeir Ali-El-Dein; Can Ali Tatar; Brant A Inman; James N'Dow; Jorg R Oddens; Marek Babjuk
Journal:  Eur Urol       Date:  2015-06-16       Impact factor: 20.096

4.  Bladder cancer--current management.

Authors:  Ranjan Arianayagam; Mohan Arianayagam; Prem Rashid
Journal:  Aust Fam Physician       Date:  2011-04

5.  A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

Authors:  H Engelmann; D Aderka; M Rubinstein; D Rotman; D Wallach
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

Review 6.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

7.  Increased inorganic phosphate induces human endothelial cell apoptosis in vitro.

Authors:  G S Di Marco; M Hausberg; U Hillebrand; P Rustemeyer; W Wittkowski; D Lang; H Pavenstädt
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-02

8.  Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms.

Authors:  Sulabha Argade; Zoltan Berecz; Yongxuan Su; C Lowell Parsons
Journal:  World J Urol       Date:  2016-03-30       Impact factor: 4.226

Review 9.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

Authors:  Marko Babjuk; Maximilian Burger; Eva M Compérat; Paolo Gontero; A Hugh Mostafid; Joan Palou; Bas W G van Rhijn; Morgan Rouprêt; Shahrokh F Shariat; Richard Sylvester; Richard Zigeuner; Otakar Capoun; Daniel Cohen; José Luis Dominguez Escrig; Virginia Hernández; Benoit Peyronnet; Thomas Seisen; Viktor Soukup
Journal:  Eur Urol       Date:  2019-08-20       Impact factor: 20.096

10.  IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation.

Authors:  Fuqing Hu; Da Song; Yumeng Yan; Changsheng Huang; Chentao Shen; Jingqin Lan; Yaqi Chen; Anyi Liu; Qi Wu; Li Sun; Feng Xu; Fayong Hu; Lisheng Chen; Xuelai Luo; Yongdong Feng; Shengyou Huang; Junbo Hu; Guihua Wang
Journal:  Nat Commun       Date:  2021-06-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.